0001209191-23-030223.txt : 20230517
0001209191-23-030223.hdr.sgml : 20230517
20230517163943
ACCESSION NUMBER: 0001209191-23-030223
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230515
FILED AS OF DATE: 20230517
DATE AS OF CHANGE: 20230517
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Soni Manmeet Singh
CENTRAL INDEX KEY: 0001569769
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37785
FILM NUMBER: 23932337
MAIL ADDRESS:
STREET 1: C/O PHARMACYCLICS, INC.
STREET 2: 995 EAST ARQUES AVE
CITY: SUNNYVALE
STATE: CA
ZIP: 94085
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REATA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001358762
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113651945
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5320 LEGACY DRIVE
CITY: PLANO
STATE: TX
ZIP: 75024
BUSINESS PHONE: 972-865-2219
MAIL ADDRESS:
STREET 1: 5320 LEGACY DRIVE
CITY: PLANO
STATE: TX
ZIP: 75024
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-05-15
0
0001358762
REATA PHARMACEUTICALS INC
RETA
0001569769
Soni Manmeet Singh
5320 LEGACY DRIVE
PLANO
TX
75024
0
1
0
0
COO, CFO and President
0
Class A common stock
2023-05-15
4
S
0
12440
84.3201
D
125864
D
Class A common stock
2023-05-15
4
S
0
8867
84.8648
D
116997
D
Class A common stock
2023-05-15
4
S
0
200
85.6425
D
116797
D
Class A common stock
2023-05-16
4
S
0
625
80.934
D
116172
D
The sale reported on this line represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $83.595 to $84.59 The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $84.595 to $85.545. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $85.635 to $85.65. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
/s/ Tracy Herson, attorney-in-fact
2023-05-17